uMotif Collaborates with The University of Manchester on Body Mapping Tool
uMotif, an eClinical platform provider powering patient-centric research, has joined up with researchers at The University of Manchester to investigate the real-world usability of its digital body mapping tool in a feasibility study in people living with musculoskeletal conditions. The University’s Manchester Digital Pain Manikin (MDPM) app has been developed by uMotif and utilizes its body mapping technology, making it faster and easier for patients to accurately report the location of their pain to study teams via their smartphone. Findings from the study are shedding light on how a digital body map can improve pain reporting, which in turn can enhance the support and care of individuals who experience long-term pain.
Data collection for The University of Manchester’s feasibility study is currently underway, with nearly 100 patients taking part through a decentralized and bring-your-own-device (BYOD) research design. A series of workshops have also taken place to gather user feedback and better understand the influence of ethnicity and cultural background on pain reporting behavior. Future studies will focus on further evaluating the tool’s validity as a research-quality pain measurement instrument. It is anticipated that this opportunity will contribute to the technology becoming a new standard for how long-term pain can be measured, analyzed, and reported.
uMotif plans to expand its concepts in body mapping technology to other therapeutic areas, such as dermatology, in the future.
uMotif Collaborates with The University of Manchester on Body Mapping Tool
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
